Early Access — free while we kick the tires
EdgarHawk

Tanguler Tolga

EVP, Chief Commercial Officer

Officer
1 filing analyzed · 1 company · Latest 2025-09-02

Companies

Company Buys Sells Direction
ALNYLAM PHARMACEUTICALS, INC. ALNY 0 6 Net selling

Activity

September 2025
medium
Sell
3,474 shares
$1,557,649
Significance 5/10

EVP/Chief Commercial Officer Tanguler Tolga sold 3,474 shares for $1,557,649.44 across 6 separate transactions on 2025-08-29.

Tanguler Tolga executed 6 separate sales on 2025-08-29 totaling 3,474 shares for $1,557,649.44, reducing his holdings by 11.8% from 29,466 shares to 25,992 shares. The blended average price of $448.37 is near the current price of $447.00 and sits 4.4% below the 52-week high of $467.55, placing the sale in the upper portion of the stock's recent trading range. ALNY remains unprofitable (full-year net income was negative) despite strong revenue growth of 23.0% year-over-year and a market cap of $58.6B, a profile typical of early-stage biotechnology companies where cash burn accompanies growth investments. The absence of prior trade data at this ticker prevents assessment of whether this pattern is consistent with the insider's historical approach to managing his ALNY position.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access